Targeting DNA damage response (DDR) pathways and exploiting synthetic lethality are important strategies for developing novel cancer therapies. DDR maintains genomic integrity by detecting and repairing DNA damage; when these pathways are compromised, cells can become reliant on alternative repair mechanisms.
ICE Bioscience supports DDR and synthetic-lethality drug research from protein expression through in vivo models, enabling identification and validation of therapeutic targets for cancer drug discovery.
Download our brochure to explore ICE Bioscience’s comprehensive DDR drug-discovery capabilities.
Download Brochure ↗We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
